Cel-Sci shares jump after FDA lifts hold; New upstart is looking for Euro marketing pacts with biotech
⇨ Shares at microcap biotech Cel-Sci $CVM jumped 36% after the biotech announced that the FDA has lifted the clinical hold on its Phase …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
